The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.
This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,490 trial records at the last sync on 25 Sep 2026, 03:16 UTC; this register shows the 2,500 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.
This page shows the 10 of those trials with a site in Acute ischemic stroke.
10 of the 2,500 most recently authorised trials in this register list a site in Acute ischemic stroke; 5 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.
| Phase | Trials | Share |
|---|---|---|
| Phase III | 5 | 50% |
| Phase II | 4 | 40% |
| Phase I/II | 1 | 10% |
| Lead sponsor | Trials |
|---|---|
| Boehringer Ingelheim International GmbH | 1 |
| Diamedica Therapeutics Inc. | 1 |
| Fondation A De Rothschild | 1 |
| Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau | 1 |
| Genesis Pharma S.A. | 1 |
| Oslo University Hospital HF | 1 |
| Takeda Development Center Americas Inc. | 1 |
| TargED Biopharmaceuticals B.V. | 1 |
| Universitaetsklinikum Heidelberg AöR | 1 |
| University Medical Center Hamburg-Eppendorf | 1 |